289 related articles for article (PubMed ID: 29306503)
1. A mouse model with age-dependent immune response and immune-tolerance for HBV infection.
Yi X; Yuan Y; Li N; Yi L; Wang C; Qi Y; Gong L; Liu G; Kong X
Vaccine; 2018 Feb; 36(6):794-801. PubMed ID: 29306503
[TBL] [Abstract][Full Text] [Related]
2. Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells.
Roh S; Kim K
Microbiol Immunol; 2003; 47(6):453-60. PubMed ID: 12906106
[TBL] [Abstract][Full Text] [Related]
3. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
4. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
[TBL] [Abstract][Full Text] [Related]
5. Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination.
Zhu D; Liu L; Yang D; Fu S; Bian Y; Sun Z; He J; Su L; Zhang L; Peng H; Fu YX
J Immunol; 2016 Apr; 196(7):3079-87. PubMed ID: 26936879
[TBL] [Abstract][Full Text] [Related]
6. Immunizations with hepatitis B viral antigens and a TLR7/8 agonist adjuvant induce antigen-specific immune responses in HBV-transgenic mice.
Wang Y; Chen K; Wu Z; Liu Y; Liu S; Zou Z; Chen SH; Qu C
Int J Infect Dis; 2014 Dec; 29():31-6. PubMed ID: 25449231
[TBL] [Abstract][Full Text] [Related]
7. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
Shimizu Y; Guidotti LG; Fowler P; Chisari FV
J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
[TBL] [Abstract][Full Text] [Related]
11. Breaking Hepatitis B Virus Tolerance and Inducing Protective Immunity Based on Mimicking T Cell-Independent Antigen.
Li X; Ni R
Viral Immunol; 2016 Nov; 29(9):502-509. PubMed ID: 27662269
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.
Zhu W; Wu C; Deng W; Pei R; Wang Y; Cao L; Qin B; Lu M; Chen X
PLoS One; 2012; 7(9):e45146. PubMed ID: 23024803
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
[TBL] [Abstract][Full Text] [Related]
14. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
[TBL] [Abstract][Full Text] [Related]
15. Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice.
Gotsman I; Israeli D; Alper R; Rabbani E; Engelhardt D; Ilan Y
Int J Cancer; 2002 Jan; 97(1):52-7. PubMed ID: 11774243
[TBL] [Abstract][Full Text] [Related]
16. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
17. Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice.
Bian Y; Zhang Z; Sun Z; Zhao J; Zhu D; Wang Y; Fu S; Guo J; Liu L; Su L; Wang FS; Fu YX; Peng H
Hepatology; 2017 Oct; 66(4):1067-1082. PubMed ID: 28445927
[TBL] [Abstract][Full Text] [Related]
18. Induction of humoral and cellular immune response to HBV vaccine can be up-regulated by STING ligand.
Ito H; Kanbe A; Hara A; Ishikawa T
Virology; 2019 May; 531():233-239. PubMed ID: 30928701
[TBL] [Abstract][Full Text] [Related]
19. CD4
Wu T; Li F; Chen Y; Wei H; Tian Z; Sun C; Sun R
Front Immunol; 2019; 10():927. PubMed ID: 31114580
[TBL] [Abstract][Full Text] [Related]
20. [Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV].
Wang G; Dong XY; Tian WH; Yu CJ; Zheng G; Gao J; Wang GJ; Wei GC; Zhou YS; Wu XB
Bing Du Xue Bao; 2012 Sep; 28(5):541-7. PubMed ID: 23233931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]